Table 2.

Clinical descriptors of our study population

DescriptorFSGS; n=20Non-FSGS Glomerular Disease; n=24Nonglomerular CKD; n=26
Immunosuppression5 (25)8 (33)11 (42)
 Tacrolimus2 (10)1 (0.4)0
 Tacrolimus/mycophenolate mofetil9 (45)5 (21)14 (54)
 Mycophenolate mofetil1 (0.50)7 (29)0
 Mycophenolate mofetil/sirolimus1 (0.5)01 (0.4)
 Azathioprine1 (0.5)1 (0.4)0
 Corticosteroid02 (0.8)0
Angiotensin converting enzyme inhibitor/angiotensin receptor blocker7 (35)10 (42)1 (0.4)
Transplant recipients (n=34)9 (45)5 (21)16 (62)
Obese000
Estimated GFR (ml/min per 1.73 m2)81.9±47.392.4±43.284.4±49.1
Urine protein/creatinine ratio2.14 (0.31–9.90)0.92 (0.28–3.61)0.65 (0.25–2.72)
  • Data are presented as n (%), mean ± SD, or median (interquartile range). P=0.60 for estimated GFR; P=0.39 for urine protein/creatinine ratio.